Medical Oncologist
CION Cancer Clinics
Indian founder variants in BRCA1: what families should know | CION Cancer Clinics
A few BRCA1 faults turn up again and again in Indian patients, but no single fault explains most Indian carriers. That is why the whole gene should be read, not just a short list of common faults. This page explains what a founder variant is, what Indian studies have found so far, and why a cheap founder-only test can give false comfort. At CION Cancer Clinics, our oncologists explain what a gene result means for you and your family, and plan the checks that follow.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Are there BRCA1 faults that are common in Indian families?
- What is known about BRCA1 faults in India?
- How does one ancestor's fault become common in a community?
- The words you will meet, in plain language
- A founder panel versus a full BRCA1 test
- Four things families tell us, and what is actually true
- What this page cannot tell you
- Common questions about founder variants in India
The short answer
Are there BRCA1 faults that are common in Indian families?
A few BRCA1 faults turn up again and again in Indian studies. But Indian families carry a very wide spread of different faults, and no single one explains most of them. That is why a full test of the gene matters more here than a short list of common faults.
What a founder variant is
A founder variant is a gene fault that began in one ancestor many generations ago. It spread through a community whose members mostly married each other. Today many unrelated-looking families in that community carry the exact same fault, because they share that distant ancestor.
How India differs from the best-known example
In Ashkenazi Jewish families, three founder faults in BRCA1 and BRCA2 account for most carriers, so a quick test for just those three works well. India is far more varied. Its many communities, languages and marriage patterns mean faults differ from region to region, and the full picture is still being mapped.
A founder variant carries broadly the same cancer risk as any other harmful BRCA1 fault. It is not a milder or worse version.What studies show
What is known about BRCA1 faults in India?
Most of this comes from hospital studies in a handful of cities. They are useful, but small.
Some faults recur
Two BRCA1 faults also known elsewhere in the world, written as c.68_69del and c.5266dup, are among those reported repeatedly in Indian patients. Several others recur within particular regions.
The spread is wide
Many Indian families carry a fault seen in only one or a few other families. Any test that checks only a short list of common faults will miss them.
What this means for testing
- The whole gene should be read
- Large missing pieces should be looked for too
- A short founder panel is not enough on its own
Communities may differ
Where marriage within a community or within the family is common, a particular fault may be more frequent locally. Studies in individual Indian communities are only beginning.
Databases are catching up
Global variant databases hold far fewer Indian samples. Indian patients are therefore more likely to receive an uncertain result, which may be reclassified later.
Not sure whether this applies to you?
Ask an oncologistHow it happens
How does one ancestor's fault become common in a community?
-
A fault arises in one person, long ago
A copying error in an egg or sperm cell creates a new BRCA1 fault. That person passes it to some of their children.
-
The community marries mostly within itself
When people choose partners from the same community, caste or extended family, the fault stays inside that group rather than being spread thin.
-
The fault spreads down many family lines
Over many generations, descendants of that one ancestor fill the community. Families who think they are unrelated can share the same distant forebear.
-
Doctors see the same fault in unrelated patients
Laboratories begin to notice one exact fault in patients who have never met. That is how a founder variant is first recognised.
-
Studies confirm the shared ancestry
Researchers check whether carriers share the stretch of DNA around the fault. If they do, the fault is traced to a common ancestor rather than arising many times.
On your report
The words you will meet, in plain language
- Founder variant
- A fault that began in one ancestor and is now shared by many families in one community.
- Recurrent variant
- A fault seen again and again in unrelated patients. It may be a founder variant, or it may have arisen more than once.
- Endogamy
- Marrying within one's own community or caste. It keeps certain faults more common within that group.
- Consanguinity
- Marriage between blood relatives, such as cousins or an uncle and niece.
- Full gene sequencing
- Reading every letter of the gene, rather than checking only a few known faults.
- Variant of uncertain significance
- A change the laboratory cannot yet classify. It is not a positive result and should not change care.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Side by side
A founder panel versus a full BRCA1 test
Founder panel only
Full gene test
Checks a short list of known faults
Reads the whole gene, letter by letter
Works well where a few faults explain most carriers
Suits varied populations like India
A negative result can give false comfort
A negative result is far more reliable
Cheaper and quicker
The standard first test for most Indian families
Commonly believed
Four things families tell us, and what is actually true
"Our community has a BRCA1 fault, so we should all be tested."
Testing is guided by your own family history, not your community alone. Outside a few well-studied groups, there is no evidence that community membership by itself calls for a test.
"The cheap test for common faults was negative, so we are clear."
Not necessarily. In India most faults are outside any short list. If your family history is strong, ask whether the whole gene was read.
"A founder fault is less dangerous because it is common."
How common a fault is says nothing about how much risk it carries. A harmful founder fault is treated like any other harmful BRCA1 fault.
"Western test results do not apply to Indians."
The gene works the same way in everyone. A fault classified as harmful is harmful in an Indian family too. What differs is which faults are found, and how many uncertain results there are.
Being straight with you
What this page cannot tell you
It cannot tell you whether the fault in your family is a founder variant, or what that means for you. Indian studies so far are small and come mostly from city hospitals. Many regions and communities have not been studied at all.
It cannot read your report
The code for a variant on your report, such as c.68_69del, does not tell you on its own what to do. What your specific variant means is a question for the counsellor who ordered the test. Please do not look up the code online and decide from that.
Who this does not apply to
Most people reading this do not need a BRCA1 test. Belonging to a particular community is not by itself a reason to test. If your family has no pattern of young breast cancer, ovarian cancer or male breast cancer, testing is unlikely to help. Counselling can take place in Telugu.
Unsure whether your earlier test read the whole gene? Call the helpline and someone will help you check.Questions we are asked
Common questions about founder variants in India
Is there a BRCA1 founder variant in Telugu families?
No single BRCA1 fault has been shown to explain most carriers in Telangana or Andhra Pradesh. Studies from South India report a wide spread of faults, with some recurring. Larger regional studies are needed before anyone can say more.
Does a founder variant change my cancer risk?
Not in any way that changes your plan. A harmful founder variant carries broadly the same risk as other harmful BRCA1 faults. Screening and risk-lowering options are the same.
My test only looked for common faults. Should I retest?
If your family history is strong, it is worth asking. A counsellor can check exactly what your earlier test covered. If it did not read the whole gene or look for large missing pieces, a fuller test may be advised.
Why did I get an uncertain result?
Global databases hold far fewer Indian samples, so laboratories have less evidence to classify many faults seen here. An uncertain result should not change your care. It may be reclassified as more Indian data builds up.
Does marrying within the family raise BRCA1 risk?
It does not change the risk that comes with a fault. It can make it more likely that a fault already in the family passes down several lines. It matters more for recessive conditions than for BRCA1.
How are my relatives tested if we have a founder variant?
Exactly as for any other BRCA1 fault. Each relative is tested for the one fault found in your family. This targeted test is simpler than the first one and usually costs less.
Can I help research on Indian BRCA1 faults?
Some hospitals and laboratories run studies or share anonymous results with variant databases. Ask your counsellor whether any study is recruiting. Taking part is always your choice and never affects your care.
Is the same true for BRCA2?
Broadly, yes. Indian BRCA2 faults are also varied, with some recurring. BRCA2 has its own page on founder variants, which covers the faults reported there.
Your Specialists
Meet CION's oncologists. Bring your family history or genetic report to them.
Our medical oncologists see people with a strong family history of cancer, arrange genetic counselling and testing where it fits, and plan the checks that follow.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- National Cancer Institute — BRCA Gene Changes: Cancer Risk and Genetic Testing
- GeneReviews (NCBI) — BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer
- MedlinePlus Genetics — BRCA1 gene
- National Cancer Institute — Genetics of Breast and Gynecologic Cancers (PDQ)
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
BRCA1 large rearrangements and why a panel can miss themThe other kind of fault a basic test can missA variant of uncertain significance in BRCA1Why uncertain results are more common in Indian patientsIndian founder variants in BRCA2The same question for the sister geneSurveillance for BRCA1 carriersWhat happens once a fault is confirmed
Talk to us
Not sure whether your earlier BRCA1 test read the whole gene?
Bring the report and your family history, and a genetic counsellor can check exactly what was tested and whether a fuller test would help. Counselling is available in Telugu. One helpline serves every CION centre.